Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12754132 [patent_doc_number] => 20180143211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/854445 [patent_app_country] => US [patent_app_date] => 2017-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15854445 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/854445
ULTRA-SMALL APOB-CONTAINING PARTICLES AND METHODS OF USE THEREOF Dec 25, 2017 Abandoned
Array ( [id] => 12641202 [patent_doc_number] => 20180105565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => Compositions and Methods for Inhibiting Tumor Cells by Inhibiting the Transcription Factor ATF5 [patent_app_type] => utility [patent_app_number] => 15/853087 [patent_app_country] => US [patent_app_date] => 2017-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853087 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/853087
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5 Dec 21, 2017 Issued
Array ( [id] => 15895307 [patent_doc_number] => 20200147172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => USE OF CREG IN TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES [patent_app_type] => utility [patent_app_number] => 16/474903 [patent_app_country] => US [patent_app_date] => 2017-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6665 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474903 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/474903
USE OF CREG IN TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES Dec 20, 2017 Abandoned
Array ( [id] => 12881134 [patent_doc_number] => 20180185553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => COLLAGEN COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/851732 [patent_app_country] => US [patent_app_date] => 2017-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15851732 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/851732
Collagen compositions and methods of use Dec 20, 2017 Issued
Array ( [id] => 13339829 [patent_doc_number] => 20180221454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => THIOREDOXIN, THIOREDOXIN PEPTIDES OR DERIVATIVES FOR TREATMENT OF AGE-RELATED HYPERTENSION [patent_app_type] => utility [patent_app_number] => 15/845376 [patent_app_country] => US [patent_app_date] => 2017-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15845376 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/845376
THIOREDOXIN, THIOREDOXIN PEPTIDES OR DERIVATIVES FOR TREATMENT OF AGE-RELATED HYPERTENSION Dec 17, 2017 Abandoned
Array ( [id] => 12908947 [patent_doc_number] => 20180194824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => MUSCLIN PEPTIDES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/841648 [patent_app_country] => US [patent_app_date] => 2017-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841648 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/841648
MUSCLIN PEPTIDES AND METHODS OF USE THEREOF Dec 13, 2017 Abandoned
Array ( [id] => 15055333 [patent_doc_number] => 10457957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Insecticidal proteins and methods of use [patent_app_type] => utility [patent_app_number] => 15/840073 [patent_app_country] => US [patent_app_date] => 2017-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 33521 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840073 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/840073
Insecticidal proteins and methods of use Dec 12, 2017 Issued
Array ( [id] => 17953496 [patent_doc_number] => 11479587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Cationic intrinsically disordered antimicrobial peptides [patent_app_type] => utility [patent_app_number] => 16/462498 [patent_app_country] => US [patent_app_date] => 2017-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 19423 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462498 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/462498
Cationic intrinsically disordered antimicrobial peptides Nov 14, 2017 Issued
Array ( [id] => 15083239 [patent_doc_number] => 20190336430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => COMPOSITIONS AND METHODS FOR BLOCKING ULTRAVIOLET RADIATION [patent_app_type] => utility [patent_app_number] => 16/349448 [patent_app_country] => US [patent_app_date] => 2017-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349448 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/349448
Compositions and methods for blocking ultraviolet radiation Nov 12, 2017 Issued
Array ( [id] => 12603474 [patent_doc_number] => 20180092988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS [patent_app_type] => utility [patent_app_number] => 15/807034 [patent_app_country] => US [patent_app_date] => 2017-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15807034 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/807034
Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs Nov 7, 2017 Issued
Array ( [id] => 12231971 [patent_doc_number] => 20180064834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'Targeted Enzymatic Degradation Of Quorum-Sensing Peptides' [patent_app_type] => utility [patent_app_number] => 15/802817 [patent_app_country] => US [patent_app_date] => 2017-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8410 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15802817 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/802817
Targeted enzymatic degradation of quorum-sensing peptides Nov 2, 2017 Issued
Array ( [id] => 16305349 [patent_doc_number] => 10774127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => Peptide dual agonists of GIPR and GLP2R [patent_app_type] => utility [patent_app_number] => 16/341082 [patent_app_country] => US [patent_app_date] => 2017-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16907 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341082 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/341082
Peptide dual agonists of GIPR and GLP2R Oct 11, 2017 Issued
Array ( [id] => 12621582 [patent_doc_number] => 20180099024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-12 [patent_title] => METHODS, COMPOSITIONS, AND KITS INVOLVING ALTERATION OF THE CHAPERONE PROTEIN AXIS IN A SUBJECT [patent_app_type] => utility [patent_app_number] => 15/726224 [patent_app_country] => US [patent_app_date] => 2017-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15726224 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/726224
METHODS, COMPOSITIONS, AND KITS INVOLVING ALTERATION OF THE CHAPERONE PROTEIN AXIS IN A SUBJECT Oct 4, 2017 Abandoned
Array ( [id] => 12157413 [patent_doc_number] => 20180028678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-01 [patent_title] => 'SELF-ASSEMBLING COMPLEX FOR TARGETING CHEMICAL AGENTS TO CELLS' [patent_app_type] => utility [patent_app_number] => 15/703323 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 11743 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703323 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/703323
Self-assembling complex for targeting chemical agents to cells Sep 12, 2017 Issued
Array ( [id] => 17323824 [patent_doc_number] => 11214820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-04 [patent_title] => Functionally modified polypeptides and radiobiosynthesis [patent_app_type] => utility [patent_app_number] => 15/695831 [patent_app_country] => US [patent_app_date] => 2017-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 15117 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695831 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/695831
Functionally modified polypeptides and radiobiosynthesis Sep 4, 2017 Issued
Array ( [id] => 15963107 [patent_doc_number] => 20200165305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => USE OF CGRP RECEPTOR ANTAGONISTS IN NEUROPROTECTION AND NEUROLOGICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 16/329596 [patent_app_country] => US [patent_app_date] => 2017-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329596 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/329596
Use of CGRP receptor antagonists in neuroprotection and neurological disorders Aug 29, 2017 Issued
Array ( [id] => 12219178 [patent_doc_number] => 20180057538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => 'POTENT AND HIGHLY SOLUBLE PEGYLATED COMPSTATIN PEPTIDES' [patent_app_type] => utility [patent_app_number] => 15/685364 [patent_app_country] => US [patent_app_date] => 2017-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13249 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685364 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/685364
POTENT AND HIGHLY SOLUBLE PEGYLATED COMPSTATIN PEPTIDES Aug 23, 2017 Abandoned
Array ( [id] => 16428289 [patent_doc_number] => 10828350 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-11-10 [patent_title] => Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment [patent_app_type] => utility [patent_app_number] => 15/679896 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 16984 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679896 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/679896
Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment Aug 16, 2017 Issued
Array ( [id] => 12178673 [patent_doc_number] => 20180037609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-08 [patent_title] => 'PHASE TRANSITION BIOPOLYMERS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/679751 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 17000 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15679751 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/679751
PHASE TRANSITION BIOPOLYMERS AND METHODS OF USE Aug 16, 2017 Abandoned
Array ( [id] => 13289241 [patent_doc_number] => 10155796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-18 [patent_title] => Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5 [patent_app_type] => utility [patent_app_number] => 15/661699 [patent_app_country] => US [patent_app_date] => 2017-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 56 [patent_no_of_words] => 15828 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661699 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/661699
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5 Jul 26, 2017 Issued
Menu